Financials data is unavailable for this security.
View more
Year on year Renascience Inc grew revenues 93.11% from 100.55m to 194.17m while net income improved from a loss of 335.80m to a smaller loss of 258.33m.
Gross margin | 78.84% |
---|---|
Net profit margin | -197.24% |
Operating margin | -196.03% |
Return on assets | -13.00% |
---|---|
Return on equity | -16.05% |
Return on investment | -13.28% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at Renascience Inc fell by 185.59m. Cash Flow from Financing totalled 46.50m or 23.95% of revenues. In addition the company used 230.52m for operations while cash used for investing totalled 1.57m.
Cash flow per share | -20.39 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 125.06 |
---|---|
Tangible book value per share | 125.06 |
More ▼
Balance sheet in JPYView more
Current ratio | 40.95 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.23 |
---|---|
Total debt/total capital | 0.187 |
More ▼